CD44 and cancer: Santisteban et al. have shown that CD8-positive T cells induce EMT in mouse mammary cancer cells; following activation, these cancer cells acquire a CSC phenotype (increased CD44+/CD24low phenotype), drug resistance, and increased tumorigenicity35.